Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Lemba BV maintains a focused patent portfolio in the Biotechnology & Pharmaceuticals technology area with 1 pending office action currently on record. This action is assigned to 1 distinct examiner working within a distinct art unit, reflecting a concentrated prosecution environment. Such a focus suggests that the company's current legal activity at the USPTO is limited to a specific technical niche.
VANHORN, ABIGAIL LOUISE serves as the busiest examiner for the company, managing the pending office action reported. With the examiner and art unit involved being the only entities on record, the prosecution path for this portfolio is entirely centralized. Practitioners can focus their efforts on the specific requirements and historical tendencies of this individual to navigate the pending matter. This focus eliminates the need to manage conflicting examiner styles or differing art unit standards, allowing for a streamlined response strategy for the pending action.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VANHORN, ABIGAIL LOUISE | 1 | 46.8% | +22.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18037234 | UMLILO ANTISENSE TRANSCRIPTION INHIBITORS | VANHORN, ABIGAIL LOUISE | 27d |
| Art Unit | Apps |
|---|---|
| 1636 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18037234 | UMLILO ANTISENSE TRANSCRIPTION INHIBITORS | VANHORN, ABIGAIL LOUISE | 1636 | §103 | Final Rejection | 27d | Pending | May 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial